Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Life Sciences Acquires Labcyte

NEW YORK (GenomeWeb) — Beckman Coulter Life Sciences announced today that it has acquired privately held liquid handling firm Labcyte.

Based in San Jose, California, Labcyte has developed an acoustic droplet ejection technology called Echo that uses sound energy for the contactless transfer of samples and reagents. Specific terms of the acquisition were not disclosed.

"Labcyte's unique product portfolio complements our existing liquid handling and laboratory automation business," Beckman Coulter Life Sciences President Jonathan Pratt said in a statement. "It provides new opportunities to develop and enhance time-saving solutions for customer workflows."

With the acquisition, Labcyte will be integrated into Indianapolis-based Beckman Coulter Life Sciences, which is a subsidiary of Danaher.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.